Understanding the State Prescription Drug Affordability Board Landscape in 2024

Several states are considering or have enacted legislation to create Prescription Drug Affordability Boards (PDABs). Although their powers vary by state, PDABs are generall charged with assessing the affordability of prescription drugs and developing recommendation to reduce spending by setting price controls. 

Join MichBio and esteemed thought leaders from patient advocacy groups and industry to examine the current PDAB landscape, the status of legislation, and what adoption of such boards may mean for patient access and innovation of new treatments. 

MODERATOR: Stephen Rapundalo, PhD, President and CEO, MichBio

SPEAKERS: 

• Laura Bonnell, President, The Bonnell Foundation
• Amy Goodman, Vice President for Policy & Advocacy, Colorado Bioscience Association
• Jen Laws, President and CEO, Community Access National Network (CANN)
• Patrick Plues, Vice President, State Government Affairs, Biotechnology Innovation Organization (BIO)
• Tiffany Westrich-Robertson, CEO, AiArthirtis

Can't make it to the live session? No problem! Register now for this free webinar and we'll send you a link to watch the program on demand at your convenience.

BROUGHT TO YOU BY: